51.22 0.00 (0.00%)
After hours: 4:16PM EDT
|Bid||51.16 x 800|
|Ask||51.17 x 800|
|Day's Range||51.09 - 51.31|
|52 Week Range||25.02 - 52.58|
|Beta (3Y Monthly)||2.06|
|PE Ratio (TTM)||24.63|
|Forward Dividend & Yield||0.32 (0.61%)|
|1y Target Est||N/A|
FRANKFURT (Reuters) - Germany's Merck KGaA, which is taking over U.S. electronic chemicals maker Versum Materials, said it expected a slight tailwind from foreign exchange effects supporting earnings growth ...
In April, Versum rejected a previous merger deal with a U.S. company in order to proceed with the buyout by Merck KGaA.
Versum Materials Inc NYSE:VSMView full report here! Summary * Bearish sentiment is low * Economic output in this company's sector is contracting Bearish sentimentShort interest | PositiveShort interest is low for VSM with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. The net inflows of $3.97 billion over the last one-month into ETFs that hold VSM are not among the highest of the last year and have been slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managersâ€™ Index (PMI) data, output in the Basic Materialsis falling. The rate of decline is significant relative to the trend shown over the past year. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Versum Materials (VSM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Versum Materials (VSM) delivered earnings and revenue surprises of 0.00% and -3.33%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Legendary investors such as Jeffrey Talpins and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that big brokerage houses don't publish. Small cap stocks -especially when they are screened well- can generate substantial outperformance versus a boring index fund. That's why we analyze the […]
NOTE: On April 17, 2019, the press release was corrected as follows: In the third sentence, the description of the affirmed rating was changed to short term issuer rating. Revised release follows. Paris, April 16, 2019 -- Moody's Investors Service, ("Moody's") has today affirmed Merck KGaA's ('Merck') issuer rating, senior unsecured Medium Term Note and subordinated ratings at Baa1, (P)Baa1 and Baa3 respectively.
The companies have inked their definitive merger agreement, and regulatory filings show that several more Versum executives will be eligible to receive hefty bonuses after the deal is consummated.
The business combination received unanimous approval from the boards of the German pharmaceutical company and Versum, Merck said in a Friday press release. Versum is a supplier of process chemicals, gases and semiconductor manufacturing equipment.
Germany's Merck KGaA sealed a $6.5 billion (4.9 billion pounds) takeover deal with Versum Materials after overturning a deal it had agreed with rival bidder Entegris. A bet on a recovery in electronic materials markets for semiconductor makers, the transaction will boost the share of profit that diversified Merck derives from high-tech chemicals to 27 percent from 19 percent previously. Merck, also maker of pharmaceuticals and biotech production gear, this week won the backing of Versum's board for its $53-per-share offer, lifted from $48 previously, having been spurned for weeks.
Merck KGaA said Friday it has signed a definitive agreement to acquire Versum Materials Inc. in a deal with an enterprise value of 5.8 billion euros ($6.6 billion). Merck will pay $53 per Versum share in cash to create a top supplier of high-purity process chemicals, gases and equipment for semiconductor manufacturing, the company said in a statement. The deal is expected to immediately boost Merck's per-share earnings and to close in the second half. Versum's board has terminated its merger agreement with Entegris Inc. on the grounds that the Merck offer is superior. The deal will be financed with cash on hand and debt via a facilities agreement with Bank of America Merrill Lynch, BNP Paribas Fortis and Deutsche Bank AG. Merck is determined to maintain its strong investment grade rating, it said in a statement. Versum shares were slightly higher premarket, but have gained 38% in the past 12 months, while the S&P 500 has gained 8%.
After last-minute whirlwind trans-Atlantic negotiations, Tempe's Versum Materials Inc. has said it wants to pull out of a deal to merge with a U.S. company in order to be acquired by a much larger German corporation.
Announcement: Moody's says revised proposal from Merck KGaA is credit positive for Versum. Global Credit Research- 09 Apr 2019. New York, April 09, 2019-- Moody's Investors Service commented on the announcement ...
Versum Materials, Inc . (NYSE: VSM ) announced Monday that it received a revised proposal from Merck KGaA to acquire Versum for $53 per share, up from Merck's prior $48-per-share proposal on Feb. 27. ...
Merck KGaA won the backing of Versum's board for a sweetened $6.5 billion (4.98 billion pounds) takeover proposal, overturning an agreed merger with rival Entegris as it bets on a recovery in electronic materials markets. "This proposal constitutes a 'Superior Proposal' as defined in Versum's previously announced merger agreement with Entegris, Inc.," Versum said in a statement on Monday. On a per share basis, Germany's Merck offered $53, up from $48 previously, after reviewing business data and following meetings between Merck Chief Executive Stefan Oschmann and Versum Chairman Seifi Ghasemi, filings showed.
Though Versum has said its board rejects a hostile takeover bid by Merck KGaA, company officials are continuing negotiations with the German suitor.
"Merck’s proposal could reasonably be expected to result in a superior proposal," Versum, a maker of chemicals for the semiconductor industry, cited its board as saying in a statement on Friday. The board "has authorized Versum's management and its advisers to engage in further discussions with, and provide non-public information to, Merck," the statement added.
FRANKFURT (Reuters) - Merck KGaA on Friday welcomed Versum Materials to the negotiation table after the takeover target said it was willing to hold talks over Merck's unsolicited offer. "We welcome ...
Versum announced in January it planned to merge with Entegris Inc. in a deal that would move the company’s headquarters out of Tempe into Entegris’ offices in Massachusetts.
German pharma group Merck KGaA launched a hostile $5.9 billion (£4.5 billion) all-cash takeover offer for Versum Materials on Tuesday to boost its presence in the semiconductor materials market and sideline a rival bidder. Versum, the former speciality chemicals division of industrial gases group Air Products, has been opposed to Merck's unsolicited cash offer since it was first proposed last month, saying it was committed to an all-share merger with U.S. rival Entegris agreed in January. Merck kept its offer price unchanged at $48 per share on Tuesday.
Versum Materials and Massachusetts-based Entegris have set April 26 as the date for stockholder meetings to vote on the companies' $9 billion proposed merger.